Max D. Wellenstein
Impact in
- Immunology top 2%
- Immune cells in cancer
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- Inflammatory Biomarkers in Disease Prognosis
- Cancer Cells and Metastasis
Papers in
- Oncology 8
- Cancer Immunotherapy and Biomarkers 5
- Inflammatory Biomarkers in Disease Prognosis 1
- Chemokine receptors and signaling 1
-
- Immune cells in cancer 7
- Immunotherapy and Immune Responses 3
- Immune Cell Function and Interaction 2
- Co-authors
- Karin E. de Visser (8 shared papers)Seth B. Coffelt (3 shared papers)Cheei‐Sing Hau (5 shared papers)Kim Vrijland (5 shared papers)Lodewyk F.A. Wessels (2 shared papers)Danique E. M. Duits (3 shared papers)Iris de Rink (1 shared paper)Stefan Preković (1 shared paper)
- Journals
- OncoImmunology (3 papers)Cell Reports (1 paper)Nature (1 paper)Nature reviews. Cancer (1 paper)Nature Biotechnology (1 paper)
- Partner nations
- NetherlandsUnited StatesUnited Kingdom
In The Last Decade
Max D. Wellenstein
10 papers receiving 2.4k citations
Max D. Wellenstein's Hit Papers
Peers
Comparison fields: 5 of 89
- Immunology 1.2k
- Oncology 1.1k
- Cancer Research 316
- Immunology and Allergy 61
- Molecular Biology 638
Countries citing papers authored by Max D. Wellenstein
This map shows the geographic impact of Max D. Wellenstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max D. Wellenstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max D. Wellenstein more than expected).
Fields of papers citing papers by Max D. Wellenstein
This network shows the impact of papers produced by Max D. Wellenstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max D. Wellenstein. The network helps show where Max D. Wellenstein may publish in the future.
Co-authors
The 25 scholars most cited alongside Max D. Wellenstein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Neutrophils in cancer: neutral no more Hit paper breakdown → | 2016 | 1340 |
| 2 | Cancer-Cell-Intrinsic Mechanisms Shaping the Tumor Immune Landscape Hit paper breakdown → | 2018 | 417 |
| 3 | Loss of p53 triggers WNT-dependent systemic inflammation to drive breast cancer metastasis Hit paper breakdown → | 2019 | 369 |
| 4 | 2017 | 86 | |
| 5 | 2016 | 49 | |
| 6 | 2022 | 40 | |
| 7 | 2023 | 27 | |
| 8 | 2022 | 26 | |
| 9 | 2023 | 12 | |
| 10 | 2023 | 7 |
About Max D. Wellenstein
Max D. Wellenstein is a scholar working on Oncology, Immunology, Molecular Biology, Psychiatry and Mental health and Cancer Research, having authored 10 papers that have together received 2.4k indexed citations. Recurring topics across this work include Immune cells in cancer (7 papers), Cancer Immunotherapy and Biomarkers (5 papers), Immunotherapy and Immune Responses (3 papers), Epigenetics and DNA Methylation (2 papers), Cancer, Stress, Anesthesia, and Immune Response (2 papers), Immune Cell Function and Interaction (2 papers), Inflammatory Biomarkers in Disease Prognosis (1 paper) and Chemokine receptors and signaling (1 paper). The work is most often cited by research in Immunology (1.2k citations), Oncology (1.1k citations), Cancer Research (316 citations), Immunology and Allergy (61 citations) and Molecular Biology (638 citations). Max D. Wellenstein has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include Karin E. de Visser, Seth B. Coffelt, Cheei‐Sing Hau, Kim Vrijland, Lodewyk F.A. Wessels, Danique E. M. Duits, Iris de Rink, Stefan Preković, Linda Henneman and Sjors M. Kas. Their work appears in journals such as OncoImmunology, Cell Reports, Nature, Nature reviews. Cancer and Nature Biotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.